Wyeth Wins FDA Approval for Kidney Cancer Drug

Wyeth's drug Torisel won U.S. approval to treat patients with a type of advanced kidney cancer known as renal cell carcinoma, the Food and Drug Administration said.

The FDA said studies showed those taking only Torisel, also known by its chemical name temsirolimus, "showed a significant improvement in overall survival."